News

Congratulations to the new professors in the Department of Internal Medicine!

The abdominal fat tissue of adolescents with insulin resistance does not appropriately respond to insulin. It could be a targetable pathway for future interventions.

Only 3% of eligible U.S. adults receive prescriptions for weight loss medications, according to research from Yale School of Medicine.

The Center for Interdisciplinary Research on AIDS at Yale University (CIRA) has selected Dr. Sunil Parikh, Yale Schools of Public Health and Medicine; Dr. Jennifer Sherr, Yale School of Medicine; and Dr. Roman Ivasiy, Yale School of Medicine, as recipients of the 2025 CIRA Pilot Projects in HIV Research Program, including the CIRA-Yale Institute for Global Health Joint Pilot Award. The awards provide funding for preliminary and feasibility studies that will lead to larger evaluations of novel interventions or implementation strategies. The CIRA-YIGH Joint Pilot Award specifically supports research addressing the syndemics of HIV/AIDS and non-communicable diseases (NCDs).

Dr. Sherr discusses childhood diabetes.

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss, and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy Kane who told her story of losing 160 pounds on weight loss medications last year on Oprah’s ABC Special: Shame, Blame and the Weight Loss Revolution.

In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss, and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy Kane who told her story of losing 160 pounds on weight loss medications last year on Oprah’s ABC Special: Shame, Blame and the Weight Loss Revolution.

NEW HAVEN, Conn. (WTNH) In today's health headlines, can GLP-1 drugs reverse prediabetes? Plus, how to reduce food noise and stick to weight loss goals during Thanksgiving week. Dr. Ania Jastreboff, Yale Medicine endocrinologist and obesity medicine physician-scientist and director of the Yale Obesity Research Center at Yale School of Medicine, discussed these topics.